| Kindred Hospice 25925 Telegraph Road, Suite 102, Southfield, MI, 48033 | |
| (248) 356-5070 |
News Archive
US researchers have used people's smartphones to amass large-scale physical activity data and measure activity patterns across populations worldwide. By looking at accelerometry data recorded on the phones, the researchers could assess physical activity levels among 717,527 people and compare it across 111 countries
Multiple sclerosis, characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease.
ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 7 days ago
| Name | Kindred Hospice |
|---|---|
| Location | 25925 Telegraph Road, Suite 102, Southfield, Michigan |
| Hospice ID | 231564 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 620 |
News Archive
US researchers have used people's smartphones to amass large-scale physical activity data and measure activity patterns across populations worldwide. By looking at accelerometry data recorded on the phones, the researchers could assess physical activity levels among 717,527 people and compare it across 111 countries
Multiple sclerosis, characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease.
ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 7 days ago
| NPI Number | 1164423703 |
| Organization Name | Odyssey Healthcare Operating B Lp |
| Address | 25925 Telegraph Rd Ste 102 Southfield, Michigan, 48033 |
| Phone Number | (248)356-5070 |
News Archive
US researchers have used people's smartphones to amass large-scale physical activity data and measure activity patterns across populations worldwide. By looking at accelerometry data recorded on the phones, the researchers could assess physical activity levels among 717,527 people and compare it across 111 countries
Multiple sclerosis, characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease.
ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 94.2 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 98.4 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 90.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 97.2 | 93.3 |
News Archive
US researchers have used people's smartphones to amass large-scale physical activity data and measure activity patterns across populations worldwide. By looking at accelerometry data recorded on the phones, the researchers could assess physical activity levels among 717,527 people and compare it across 111 countries
Multiple sclerosis, characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease.
ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 7 days ago
| Home Health Aides | 2 |
| Counselors | 2 |
| Medical Social Workers | 3 |
| Registered Nurses | 16 |
| Other Personnel | 1 |
| Total Employees | 24 |
|---|
News Archive
US researchers have used people's smartphones to amass large-scale physical activity data and measure activity patterns across populations worldwide. By looking at accelerometry data recorded on the phones, the researchers could assess physical activity levels among 717,527 people and compare it across 111 countries
Multiple sclerosis, characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease.
ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
› Verified 7 days ago
| Hospice Of Michigan Location: 26957 Northwestern Hwy 140, Southfield, Michigan, 48033 Phone: (248) 356-5070 |
| Kindred Hospice Location: 25925 Telegraph Road, Suite 102, Southfield, Michigan, 48033 Phone: (248) 356-5070 |
| Heartland Home Health Care And Hospice Location: 26211 Central Park Blvd, Suite 600, Southfield, Michigan, 48076 Phone: (248) 356-5070 |
| Universal Hospice Care Location: 24315 Northwestern Highway, Suite 102, Southfield, Michigan, 48075 Phone: (248) 356-5070 |